Aptevo Therapeutics Inc (APVO)
US$ 0.39-4.88%
Price Chart
Key Statistics
Market Cap
$ 2.78M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
697.22K
52W High
$ 33.67
52W Low
$ 0.34
Dividend Yield
0.00%
Beta
6.06
Technicals
50-Day MA
1.8023
200-Day MA
7.1767
52 Week High
33.67
52 Week Low
0.345
About APVO
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United.
Employees
37
Headquarters
Seattle, WA
CEO
Mr. Marvin L. White
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg